Table 1.
Correlation between serum microRNA (miR)-142-3p level and clinical variables of patients with colorectal cancer.
| Characteristic | Serum miR-142-3p |
p-value | |
|---|---|---|---|
| High (n = 127) | Low (n = 236) | ||
| Age (years) | 0.38 | ||
| ≥60 | 61 | 102 | |
| <60 | 66 | 134 | |
| Sex | 0.70 | ||
| Male | 79 | 142 | |
| Female | 48 | 94 | |
| Tumor site | 0.07 | ||
| Colon | 56 | 81 | |
| Rectum | 71 | 155 | |
| Tumor size (cm) | 0.92 | ||
| ≥5 | 48 | 88 | |
| <5 | 79 | 148 | |
| T stage | <0.01 | ||
| T1 + T2 | 84 | 107 | |
| T3 | 43 | 129 | |
| Node involvement | 0.80 | ||
| N0 | 51 | 98 | |
| N1 | 76 | 138 | |
| Clinical stage (TNM) | <0.01 | ||
| I + II | 79 | 81 | |
| III | 48 | 155 | |
| Pathological differentiation | 0.24 | ||
| Good/moderate | 71 | 147 | |
| Poor | 56 | 89 | |
OS, overall survival; CI, confidence interval; HR, hazard ratio; miR-142-3p, microRNA-142-3p.